Clinical Trials Logo

Clinical Trial Summary

Prospective, multicenter, open-label, randomized and controlled study of the effects of weight loss and reduced visceral fat on non-alcoholic fat infiltration into liver after a very low calorie ketogenic diet (VLCK diet) (Pronokal® Method) versus a hypocaloric diet, with a 6-month follow-up.


Clinical Trial Description

The investigators will include obese patients with BMI higher than 30 kg / m2 to follow a standardized multidisciplinary weight-loss program (PronoKal® Method), which consists of a very-low-calorie diet, into which natural foods are gradually reintroduced, accompanied by physical exercise and emotional support, versus hypocaloric diet.

The aim of this study are see the reduction of fatty liver, visceral fat and improvement of hepatic stiffness during the weight loss treatment.

Patients will be visited monthly and data will recorded on 4 occasions: pre-inclusion, initial visit, 2-months visit (end of ketosis) and 6-months visit.

Hepatic fatty infiltration and visceral fat will be scanned by MRI and hepatic stiffness will be assessed by MR Elastography at: baseline, 2 months and 6 months. Also will be recorded anthropometric data (weight, BMI, waist circumference) and complete blood tests. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04322110
Study type Interventional
Source Protein Supplies SL
Contact
Status Completed
Phase N/A
Start date September 12, 2016
Completion date October 25, 2017

See also
  Status Clinical Trial Phase
Completed NCT02194504 - The Belly Fat Study: Nutritional Intervention to Improve Metabolic Health in Subjects With Increased Abdominal Adiposity N/A
Recruiting NCT05499585 - Treating Pediatric NAFLD With Nutrition N/A
Completed NCT01729078 - Dietary Interventions in Prediabetes N/A
Recruiting NCT05294471 - Fully Automated High-Throughput Quantitative MRI of the Liver
Recruiting NCT05751720 - Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue Phase 1/Phase 2
Completed NCT02282475 - Role of Liver and Visceral Fat in Glucose and Lipid Metabolism During Pregnancy
Not yet recruiting NCT05644717 - Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD Phase 4
Completed NCT05895916 - Extreme Exercise and Energy Expenditure (4E) Study N/A
Completed NCT03528031 - Habitual Diet and Avocado Trial N/A
Recruiting NCT05968378 - Diet, Immunometabolism and Non-alcoholic Fatty Liver Disease N/A
Not yet recruiting NCT06138821 - ESG vs GLP-1RA vs ESG + GLP-1RA in Patients With Obesity, NAFLD and Advanced Fibrosis: A Randomized Controlled Trial Phase 4
Recruiting NCT02204670 - EXIT: Prospective Study of the Response to Exercise N/A
Recruiting NCT06111859 - Effectiveness of Ultrasound in Liver Stiffness and Fat Quantification N/A
Active, not recruiting NCT03375788 - Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk Phase 2
Completed NCT04644887 - Liver, Diet and Genetic Background N/A
Recruiting NCT05962190 - Short-term Fat Overfeeding on the Effects of Liver Metabolism N/A
Recruiting NCT04899102 - Intermittent Fasting for NAFLD in Adults N/A
Completed NCT03231839 - Nutritional Prevention of Diabetes Mellitus Type 2 N/A
Completed NCT03204461 - Glucose Metabolism in Different PCOS Phenotypes N/A
Completed NCT02144597 - Low-calorie Diet and Body Composition Prior to Roux-en-Y Gastric Bypass N/A